Ingevity (NGVT) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
29 Apr, 2026Opening remarks and agenda
Chair welcomed stockholders, introduced board members, and acknowledged two departing directors for their service.
Leadership team, independent auditors, and Inspector of Elections were introduced.
Agenda and meeting rules were made available on the virtual platform; polls were opened for voting.
Board and executive committee updates
Two founding board members, Jean Blackwell and Dan Cecconi, were recognized for their contributions as they step down.
Incoming CFO Phil Platt was introduced among the leadership team.
Shareholder proposals
Four proposals were presented: election of nine directors, advisory vote on executive compensation, ratification of auditors, and amendment to increase shares under the 2025 Omnibus Incentive Plan.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Ingevity
- Adjusted EBITDA rose 14% to $115M, margin hit 36.6%, and full-year guidance was raised.NGVT
Q2 2026 - Transformation drives high-margin growth in core businesses, with innovation and regulatory tailwinds.NGVT
16th Annual Wells Fargo Industrials & Materials Conference - Sharpened focus on core businesses drives profitability, innovation, and sustainability leadership.NGVT
Investor presentation - Q1 net sales up 4% to $258M, stable EBITDA, major divestitures, and 2026 outlook reaffirmed.NGVT
Q1 2026 - Strategic transformation, board refreshment, and strong financial and ESG performance drive key proposals.NGVT
Proxy Filing - Board recommends approval of all proposals, including director elections and incentive plan changes.NGVT
Proxy Filing - Adjusted EBITDA margin rose to 31.9%, free cash flow reached $274M, and leverage improved to 2.6x.NGVT
Q4 2025 - Q2 net loss of $283.7M on $390.6M sales, with major goodwill impairment and restructuring.NGVT
Q2 2024 - Q3 2024 net sales fell 16% to $376.9M with a $107.2M net loss, but guidance was reaffirmed.NGVT
Q3 2024